New Topic Page: Kidney Cysts
Visit the new MedlinePlus Health Topic page on kidney cysts.
A cyst is a fluid-filled sac. There are two types of kidney cysts...
Director’s Comments: Exercise & Type-2 Diabetes Therapy
Listen to the NLM Director's Comments on "Exercise & Type-2 Diabetes Therapy". The transcript is also available.
Structured exercise programs are more successful than increases in training intensity or counseling in lowering the blood sugar levels of adults with type-2 diabetes, finds an analysis of 47 clinical trials recently published in the Journal of the American Medical Association...
MedlinePlus Drug Sharing Enhancement
MedlinePlus now offers a new way to share up-to-date drug content.
Starting today, you can use the share buttons on each drug information page to send links to your social networks, such as Facebook or Twitter. Look for the Share buttons on all drug information pages on MedlinePlus.
No headway against COPD, which now affects women more – KTVN
 ThirdAge | No headway against COPD, which now affects women more KTVN WEDNESDAY, June 29 (HealthDay News) -- Between 1998 and 2009 there was no significant decline in cases of the often deadly ailment known as chronic obstructive pulmonary disease (COPD), and the burden of the disease has shifted from ... Panax ginseng CA Meyer root extract for moderate Chronic Obstructive Pulmonary ...7thSpace Interactive (press release) COPD Rates Remain Stable in US Between 1998 and 2009MD News (press release) Chronic Obstructive Pulmonary Disease Numbers Remained Stable, Report SaysThirdAge all 13 news articles » |
No headway against COPD, which now affects women more – KTVN
ThirdAge | No headway against COPD, which now affects women more KTVN WEDNESDAY, June 29 (HealthDay News) -- Between 1998 and 2009 there was no significant decline in cases of the often deadly ailment known as chronic obstructive pulmonary disease (COPD), and the burden of the disease has shifted from ... Panax ginseng CA Meyer root extract for moderate Chronic Obstructive Pulmonary ...7thSpace Interactive (press release) COPD Rates Remain Stable in US Between 1998 and 2009MD News (press release) Chronic Obstructive Pulmonary Disease Numbers Remained Stable, Report SaysThirdAge all 13 news articles » |
No headway against COPD, which now affects women more – KTVN
ThirdAge | No headway against COPD, which now affects women more KTVN WEDNESDAY, June 29 (HealthDay News) -- Between 1998 and 2009 there was no significant decline in cases of the often deadly ailment known as chronic obstructive pulmonary disease (COPD), and the burden of the disease has shifted from ... Panax ginseng CA Meyer root extract for moderate Chronic Obstructive Pulmonary ...7thSpace Interactive (press release) COPD Rates Remain Stable in US Between 1998 and 2009MD News (press release) Chronic Obstructive Pulmonary Disease Numbers Remained Stable, Report SaysThirdAge all 13 news articles » |
No headway against COPD, which now affects women more – MyFox Wausau
ThirdAge | No headway against COPD, which now affects women more MyFox Wausau WEDNESDAY, June 29 (HealthDay News) -- Between 1998 and 2009 there was no significant decline in cases of the often deadly ailment known as chronic obstructive pulmonary disease (COPD), and the burden of the disease has shifted from ... COPD Rates Remain Stable in US Between 1998 and 2009MD News (press release) Panax ginseng CA Meyer root extract for moderate Chronic Obstructive Pulmonary ...7thSpace Interactive (press release) No headway against COPD, which now affects women moreWBRC WFIE-TV -ThirdAge all 13 news articles » |
Study Shows Novartis Lung Drug Effective In “Smokers Cough” COPD – NASDAQ
 OneMedPlace (blog) | Study Shows Novartis Lung Drug Effective In "Smokers Cough" COPD NASDAQ Novartis Thursday saidt a phase III study, named GLOW2, showed NVA237 was superior to placebo in treating patients suffering from moderate-to-severe chronic obstructive pulmonary disease, or COPD. The study also found the drug was well tolerated and ... Novartis Phase III study shows once-daily NVA237 is superior to placebo and ...Reuters (press release) Novartis unveils more promising Ph3 data on COPD programFierceBiotech Novartis' NVA237 Found Similar To Tiotropium In Improving Lung FunctionRTT News PR Newswire (press release) -Pharmaceutical Business Review -Cabume - Cambridge technology news all 35 news articles » |
Forest Laboratories, Almirall file COPD drug NDA with FDA – Pharmaceutical Business Review
Forest Laboratories, Almirall file COPD drug NDA with FDA Pharmaceutical Business Review Forest Laboratories and Almirall have filed a new drug application (NDA) for an inhaled antimuscarinic agent aclidinium bromide with the US Food and Drug Administration (FDA) as a treatment for chronic obstructive pulmonary disease (COPD). ... Forest and Almirall Announce Submission of New Drug Application for Aclidinium ...MarketWatch (press release) Forest/Almirall's COPD drug filed in USAPharma Times FOREST LABORATORIES, ALMIRALL SUBMITTED NDA TO FDA (FRX)Zacks.com all 18 news articles » |
Forest and Almirall Announce Submission of New Drug Application for Aclidinium … – MarketWatch (press release)
Forest and Almirall Announce Submission of New Drug Application for Aclidinium ... MarketWatch (press release) MC) announced they have recently submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for aclidinium bromide, a long-acting inhaled antimuscarinic agent developed for the treatment of COPD. ... and more » |